Postoperative Adjuvant Imatinib Therapy-Associated Nomogram to Predict Overall Survival of Gastrointestinal Stromal Tumor

BACKGROUND: Adjuvant imatinib therapy has been shown to improve overall survival (OS) of gastrointestinal stromal tumor (GIST) significantly. Few nomograms combining the use of adjuvant imatinib and clinicopathological characteristics estimate the outcome of patients. We aimed to establish a more co...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuechao, Lin, Enyu, Sun, Yuqi, Liu, Xiaodong, Li, Zequn, Jiao, Xuelong, Li, Yi, Guo, Dong, Zhang, Peng, Feng, Xingyu, Chen, Tao, Niu, Zhaojian, Zhou, Zhiwei, Qiu, Haibo, Zhou, Yanbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960199/
https://www.ncbi.nlm.nih.gov/pubmed/35360729
http://dx.doi.org/10.3389/fmed.2022.777181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960199/
https://www.ncbi.nlm.nih.gov/pubmed/35360729
http://dx.doi.org/10.3389/fmed.2022.777181

Ejemplares similares